Citadel Advisors’s T. Rowe Price Health Care ETF TMED Stock Holding History

Citadel Advisors’s Portfolio TMED Stock Details TMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.93M	Buy	66,660 +39,059	+142%	+$1.16M	﹤0.01%	6136
2025 Q4	$820K	Sell	27,601 -2,173	-7%	-$63.1K	﹤0.01%	7851
2025 Q3	$794K	Buy	29,774 +20,189	+211%	+$508K	﹤0.01%	8044
2025 Q2	$238K	Buy	+9,585	New	+$237K	﹤0.01%	10330

Other funds holding TMED

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

EFS

Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return

Citadel Advisors's TMED Position: Q1 2026 in Review

Citadel Advisors increased its T. Rowe Price Health Care ETF (TMED) stake by 142% in Q1 2026, buying an estimated $1.16M and bringing the position to 66,660 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #6136.

Citadel Advisors first reported a position in TMED in Q2 2025 and has held it in 4 quarters since. 4 funds tracked by Wall St. Rank hold TMED as of Q1 2026.

Citadel Advisors held 66,660 shares of T. Rowe Price Health Care ETF worth $1.93M as of Q1 2026.
Citadel Advisors bought 39,059 T. Rowe Price Health Care ETF shares in Q1 2026, an estimated $1.16M.
T. Rowe Price Health Care ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6136 holding.
Citadel Advisors first reported a position in T. Rowe Price Health Care ETF in Q2 2025 and has held it in 4 quarters since.
4 funds tracked by Wall St. Rank held T. Rowe Price Health Care ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.